HUP0002727A2 - Eljárás fibrinogén csökkentésére benzotiofénszármazékok felhasználásával - Google Patents

Eljárás fibrinogén csökkentésére benzotiofénszármazékok felhasználásával

Info

Publication number
HUP0002727A2
HUP0002727A2 HU0002727A HUP0002727A HUP0002727A2 HU P0002727 A2 HUP0002727 A2 HU P0002727A2 HU 0002727 A HU0002727 A HU 0002727A HU P0002727 A HUP0002727 A HU P0002727A HU P0002727 A2 HUP0002727 A2 HU P0002727A2
Authority
HU
Hungary
Prior art keywords
methods
reducing fibrinogen
benzotiophene
derivatives
fibrinogen
Prior art date
Application number
HU0002727A
Other languages
English (en)
Inventor
Pamela W. Anderson
Original Assignee
Eli Lilly And Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Co. filed Critical Eli Lilly And Co.
Publication of HUP0002727A2 publication Critical patent/HUP0002727A2/hu
Publication of HUP0002727A3 publication Critical patent/HUP0002727A3/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Abstract

A találmány tárgya eljárás fibrinogén csökkentésére emberekben, amelyeljárás abból áll, hogy embereknek 2-aroil-3-aril-benzo[b]tiofénvegyületeket, elsősorban (I) általános képletű vegyületeket , ahol aképletben R jelentése N-pirrolidinil- vagy N-piperidinilcsoport, vagyezek sóit vagy szolvátjait adják be. Ó
HU0002727A 1997-04-22 1998-04-20 Methods for reducing fibrinogen using benzotiophene derivatives HUP0002727A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4459197P 1997-04-22 1997-04-22
PCT/US1998/007862 WO1998047365A1 (en) 1997-04-22 1998-04-20 Methods for reducing fibrinogen

Publications (2)

Publication Number Publication Date
HUP0002727A2 true HUP0002727A2 (hu) 2001-08-28
HUP0002727A3 HUP0002727A3 (en) 2001-09-28

Family

ID=21933208

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0002727A HUP0002727A3 (en) 1997-04-22 1998-04-20 Methods for reducing fibrinogen using benzotiophene derivatives

Country Status (23)

Country Link
US (1) US6025373A (hu)
EP (1) EP0878195B1 (hu)
JP (1) JP2001524101A (hu)
KR (1) KR20010012084A (hu)
CN (1) CN1254255A (hu)
AT (1) ATE219364T1 (hu)
AU (1) AU741720B2 (hu)
BR (1) BR9809286A (hu)
CA (1) CA2287196A1 (hu)
DE (1) DE69806098T2 (hu)
DK (1) DK0878195T3 (hu)
EA (1) EA002237B1 (hu)
ES (1) ES2178111T3 (hu)
HU (1) HUP0002727A3 (hu)
ID (1) ID22910A (hu)
IL (1) IL132504A0 (hu)
NO (1) NO995132L (hu)
NZ (1) NZ500389A (hu)
PL (1) PL336638A1 (hu)
PT (1) PT878195E (hu)
TR (1) TR199902605T2 (hu)
WO (1) WO1998047365A1 (hu)
ZA (1) ZA983298B (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103740A (en) * 1997-08-21 2000-08-15 Eli Lilly And Company Methods for lowering platelet counts
FR2777784B1 (fr) * 1998-04-27 2004-03-19 Arepa Composition pharmaceutique a base d'estrogene et de progesterone
US6353003B1 (en) * 1998-06-17 2002-03-05 Eli Lilly And Company Method for reducing levels of homocysteine and C-reactive protein

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US5075321A (en) * 1987-03-24 1991-12-24 University Of Pennsylvania Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
WO1993011704A1 (en) * 1991-12-17 1993-06-24 Eduard Emmanuilovich Godik Method and device for diagnosis of living organism
US5482949A (en) * 1993-03-19 1996-01-09 Eli Lilly And Company Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
US5445941A (en) * 1993-06-21 1995-08-29 Eli Lilly And Company Method for screening anti-osteoporosis agents
CZ253694A3 (en) * 1993-10-15 1995-05-17 Lilly Co Eli Pharmaceutical preparation for treating resistant neoplasms
US5476862A (en) * 1993-12-21 1995-12-19 Eli Lilly And Company Methods of increasing thrombomodulin expression
US5441965A (en) * 1993-12-21 1995-08-15 Eli Lilly And Company Methods of inhibiting thrombin
HUP9801829A3 (en) * 1995-02-06 1999-10-28 Lilly Co Eli Use of benzotiophene derivatives for producing pharmaceutical compositions for inhibiting effects of il-6
US5731328A (en) * 1995-10-10 1998-03-24 Eli Lilly And Company Methods of inhibiting plasminogen activator inhibitor 1

Also Published As

Publication number Publication date
EP0878195A1 (en) 1998-11-18
PT878195E (pt) 2002-09-30
TR199902605T2 (xx) 2000-02-21
US6025373A (en) 2000-02-15
CA2287196A1 (en) 1998-10-29
WO1998047365A1 (en) 1998-10-29
EP0878195B1 (en) 2002-06-19
MX9909548A (es) 2003-02-27
BR9809286A (pt) 2000-07-04
HUP0002727A3 (en) 2001-09-28
EA199900959A1 (ru) 2000-06-26
ATE219364T1 (de) 2002-07-15
ES2178111T3 (es) 2002-12-16
NO995132D0 (no) 1999-10-21
KR20010012084A (ko) 2001-02-15
NO995132L (no) 1999-10-21
PL336638A1 (en) 2000-07-03
EA002237B1 (ru) 2002-02-28
AU7250398A (en) 1998-11-13
AU741720B2 (en) 2001-12-06
CN1254255A (zh) 2000-05-24
DE69806098D1 (de) 2002-07-25
ZA983298B (en) 1999-10-20
DE69806098T2 (de) 2003-01-02
IL132504A0 (en) 2001-03-19
NZ500389A (en) 2001-07-27
JP2001524101A (ja) 2001-11-27
DK0878195T3 (da) 2002-07-15
ID22910A (id) 1999-12-16

Similar Documents

Publication Publication Date Title
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
EE9900217A (et) Sulfiinhappe derivaadid, nende valmistamine ja kasutamine
DE60204452D1 (de) Pyrazolo[1,5]pyridinderivate
PT923554E (pt) N-benzilpiperidina e derivados tetrahidropiridina
MX9707453A (es) Derivados de quinazolina.
NO302474B1 (no) Sakarinderivater, farmasöytisk sammensetning og anvendelse derav
BR0012243A (pt) Triflúor butenos nematocidas
MY107740A (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
PT896533E (pt) Pentafluorobenzenosulfonamidas e analogos
BR9811099A (pt) Inibidores de urocinase
DE60121461D1 (de) Kondensierte pyridoindolderivate
EA200000204A1 (ru) Производные пирролопирролона в качестве ингибиторов эластазы нейтрофилов
CY1106376T1 (el) Δικυκλικα παραγωγα των αμινο-πυραζινονων, μεθοδος παρασκευης τους και οι φαρμακευτικες συνθεσεις που τα πepιεχουν
AP2001002188A0 (en) 5HT1 antagonists for antidepressant therapy.
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
ATE253359T1 (de) Antithrombotische mittel
DE69330601T2 (de) Serotoninergische ergolin derivate
HUP0002727A2 (hu) Eljárás fibrinogén csökkentésére benzotiofénszármazékok felhasználásával
BG103271A (en) Derivatives of n-(benzothiazol-2-yl) piperidine-1-ethaneamines, method for their preparation and application as therapeutical means
DE69828522D1 (de) Antithrombotische mittel
TR200400907T4 (tr) Beta D 5-Tiyoksiloz türevleri, bunları hazırlama yöntemi ve bunların terapötik kullanımları
PT1104419E (pt) Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao
ATE286892T1 (de) Hydroxam- und carbonsäurederivate mit mmp- und tnf-hemmender aktivität
ATE228359T1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
EA199900020A2 (ru) Способ получения нафтиридонов и промежуточных соединений